Durvalumab after chemo-radiotherapy in stage III non-small cell lung cancer

類似資料

• Durvalumab after chemoradiotherapy in stage III non-small cell lung cancer
  著者:: Tomasini, Pascale, 等
  出版事項: (2018)
• Durvalumab showed long and durable effects after chemoradiotherapy in stage III non-small cell lung cancer: results of the PACIFIC study
  著者:: Uemura, Takehiro, 等
  出版事項: (2018)
• Treatment outcome and toxicity of intensity-modulated (chemo) radiotherapy in stage III non-small cell lung cancer patients
  著者:: Govaert, Stephanie LA, 等
  出版事項: (2012)
• Consolidation treatment of durvalumab after chemoradiation in real‐world patients with stage III unresectable non‐small cell lung cancer
  著者:: Chu, Chia‐Hsun, 等
  出版事項: (2020)
• Immune checkpoint blockade for advanced non-small cell lung cancer: challenging clinical scenarios
  著者:: Tay, Rebecca, 等
  出版事項: (2018)